Ana Sayfa Profiller

SKA İş Birlikleri

ARC

ARC

Research Arc - Akademik Araştırma ve İşbirliği

Tüm hakları saklıdır. Metin ve veri madenciliği, yapay zeka eğitimi ve benzeri teknolojiler dahil olmak üzere içerik hakları korunur.

Hızlı Linkler

Profiller Araştırma Çıktıları Yayınlar Projeler Araştırma Alanları Patentler SKA İş Birlikleri

Telif Hakkı 2026 © ARC, SparkLab Bilgi Teknolojileri A.Ş. Ürünüdür. Tüm hakları saklıdır.

SAADETTİN KILIÇKAP

Profesör

İstinye Üniversitesi

Tıp Fakültesi

İç Hastalıkları Anabilim Dalı (İngilizce)

saadettin.kilickap@istinye.edu.tr

iDORCID0000-0003-1637-7390

YÖKYÖKID-

SCSCOPUSID8665552100

WoSWOSIDAAP-3732-2021

Atıflar

4.953

H-Index (Scopus)

31

Genel Bakış
Özgeçmiş
Araştırma Alanları
İş Birliği
Yayınlar
Projeler
Dersler
Tez Danışmanlıkları
Fikri Mülkiyet
Ödüller
Diğer Faaliyetler

Yayın Bul

Kayıt bulundu: 742

0 aktif filtre

SCScopus

WoS

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer

Cengiz M.

Discover Oncology, 2026

SCMakaleQ3Açık erişimImmunotherapy Advances in Non-Small Cell Lung CancerImmune Checkpoint Inhibitors in Cancer Therapy

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab

Ağdaş G.

Scientific Reports, 2026

SCMakaleQ1Açık erişimImmunotherapy Advances in Non-Small Cell Lung CancerImmune Checkpoint Inhibitors in Cancer Therapy

Prognostic value of the Scottish Inflammatory Prognostic Score in advanced NSCLC treated with second-line nivolumab

Kolemen E.

Discover Oncology, 2026

SCMakaleQ3Açık erişimImmunotherapy Advances in Non-Small Cell Lung CancerImmune Checkpoint Inhibitors in Cancer Therapy

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients

Cengiz M.

Scientific Reports, 2026

SCMakaleQ1Açık erişimPharmacokinetics of Immune Checkpoint InhibitorsImmune Checkpoint Inhibitors in Cancer Therapy

Preimplantation genetic testing (PGT-M) awareness in BRCA-positive individuals in Türkiye: a dual physician–patient survey

Cicin I.

Scientific Reports, 2026

SCMakaleQ1Açık erişimPreimplantation Genetic Diagnosis and Decision MakingGenetic Insights into Intersex Conditions and Disorders

Intracholecystic Papillary Neoplasm Mimicking High-Grade Dedifferentiation in a Patient With Neuroendocrine Tumor: The Value of Dual-Tracer PET/CT

Simsir C.

Clinical Nuclear Medicine, 2026

SCMakaleQ3Intraductal Papillary Neoplasms in Biliary TractDiagnostic Innovations in Pancreatic and Gastric Tumors

Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

Demircan N.C.

Journal of Immunotherapy, 2026

Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study

Demircan, NC

JOURNAL OF IMMUNOTHERAPY, 2026

Real-World Efficacy and Safety of Tyrosine Kinase Inhibitors in Patients With Advanced Bone Sarcomas: The TOGBONE Study of the Turkish Oncology Group

Fidan M.C.

JCO Global Oncology, 2026

SCMakaleAçık erişim

Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors A Multicenter Study by the Turkish Oncology Group (TOG)

Demir, O

JOURNAL OF IMMUNOTHERAPY, 2026

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Kıkılı C.İ.

Clinical Genitourinary Cancer, 2026

SCMakaleQ2Molecular Subtypes and Treatment Strategies in Bladder CancerOutcomes and Innovations in Bladder Cancer Treatment

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Kikili, CI

CLINICAL GENITOURINARY CANCER, 2026

Sayfa 1 / 62